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A lthough the prognosis following esophagectomy for esophageal cancer has improved due to recent 
advances in multidisciplinary treatment and periopera-
tive care [1],  it has been reported that approximately 
4% of patients with esophageal cancer develop a second 
primary malignancy in the upper gastrointestinal trunk 
[2 , 3].  Surgical interventions including gastrectomy and 
pancreatoduodenectomy for second primary malignan-
cies in the upper gastrointestinal trunk have been 
reported in patients following esophagectomy [3 , 4].  
However,  to date few studies have reported on cases of 
esophageal cancer in which hepatectomy was per-
formed following esophagectomy.  A gastric tube has 
often been used as an esophageal substitute in alimen-
tary tract reconstruction in patients undergoing 
esophagectomy for esophageal cancer [4 , 5].  Therefore 
special attention to the gastric tube is necessary when 
abdominal surgery is performed following esophagec-
tomy.  Herein,  we present the case of a patient who 
underwent left hemihepatectomy for hepatocellular 
carcinoma (HCC) nine years after esophagectomy with 
retrosternal gastric tube reconstruction for esophageal 
cancer.
Case Report
A 70-year-old man underwent neoadjuvant chemo-
radiotherapy and esophagectomy for esophageal cancer 
with retrosternal gastric tube reconstruction at our 
institute.  The details of the surgical procedure were 
described previously [6].  Nine years later,  at his annual 
follow-up,  positron emission tomography/computed 
tomography (PET/CT) revealed a large liver tumor with 
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no symptoms.  Abdominal CT images revealed a 9 cm 
tumor at the left lateral segment.  The tumor com-
pressed the umbilical portion,  as the tumor thrombus 
protruded into the left portal vein,  and also com-
pressed the middle hepatic vein.  The enhancement 
pattern on the CT image showed early arterial enhance-
ment with rapid washout,  suggesting the presence of 
HCC rather than liver cancer that had metastasized 
from esophageal cancer.  Therefore,  we diagnosed the 
tumor as HCC accompanied by a portal vein tumor 
thrombus,  and not as an extrahepatic metastasis.  The 
CT also confirmed the gastric tube running through the 
retrosternal pathway as well as the right gastroepiploic 
artery.  The CT images are shown in Fig. 1.
The laboratory values were as follows: total bilirubin,  
0.99 mg/dL; alanine transaminase,  20 IU/L; albumin,  
4.2 g/dL; and prothrombin time,  104%.  The tumor 
markers were elevated: alpha-fetoprotein,  27,462 ng/mL;  
prothrombin induced by vitamin K absence or antago-
nist-II,  4,699 mAU/mL.  The serological markers for 
hepatitis B virus (HBV) showed a hepatitis B virus sur-
face antigen (HBsAg) seroconversion pattern: HBsAg 
negative,  hepatitis B e antigen negative,  antihepatitis 
B e antibody positive (77%),  antibodies to hepatitis B 
core antigen positive (17.6 s/co),  antihepatitis B surface 
antigen antibody positive (344 mIU/mL),  and unde-
tectable HBV-DNA.  Hepatitis C virus antibody was 
negative.  The patient had undergone no treatment for 
HBV infection,  and his family history of HBV infection 
was unknown.  In addition,  the patient had a history of 
alcohol abuse prior to undergoing esophagectomy for 
esophageal cancer.  
With respect to the liver functional reserve,  the 
indocyanine green retention rate at 15 min was 15.8%,  
and the Child-Pugh classification was grade A (score 5).  
The technetium-99 m-galactosyl human serum albumin 
showed the following results: the clearance index (HH15) 
was 0.518,  and the receptor index (LHL5) was 0.867.  
Accordingly,  a left hemihepatectomy was scheduled.  
Following the dissection of the adhesions around the 
liver,  the gastric tube was encircled (Fig. 2A).  The left 
lobe of the liver was stuck under the gastric tube,  and 
thus we were unable to mobilize the left lobe and per-
form the extrahepatic Glissonean approach.  Therefore,  
the liver parenchyma was initially dissected along Rex-
Cantlie’s line using a Cavitron Ultrasonic Surgical 
Aspirator and vessel sealing system (LigaSure).  
Subsequently,  the left hepatic artery and the left portal 
vein were identified and transected,  and the left hepatic 
duct was then divided.  Finally,  the middle hepatic vein 
and left hepatic vein were transected to achieve com-
plete dissection of the liver parenchyma.  During sur-
gery,  it was necessary to pay additional attention to the 
gastric tube as well as the right gastroepiploic artery in 
order to prevent incidental injury (Fig. 2B).  The total 
operative time was 239 minutes,  and the estimated 
blood loss was 350 mL.
The patient was discharged on postoperative day 
eight with an uneventful course.  The pathological find-
ings confirmed moderately differentiated HCC with 
microvascular invasions into the secondary branch of 
the portal vein (vp2) and peripheral hepatic vein (vv1).
Discussion
To the best of our knowledge,  this report is the first 
to highlight the technical aspects of hepatectomy fol-
lowing esophagectomy with retrosternal gastric tube 
reconstruction.  We found that hepatectomy following 
esophagectomy was feasible.  Furthermore,  special 
attention should be paid to avoid incidental injury of the 
gastric tube as well as the right gastroepiploic artery 
during hepatectomy following esophagectomy with gas-
tric tube reconstruction.  
The treatment strategy for complicated cases with 
HCC should be determined depending on availability 
and experience of facilities.  According to the clinical 
practice guidelines,  hepatectomy,  embolization,  
hepatic arterial infusion chemotherapy,  and molecu-
lar-targeted therapy are recommended for patients with 
HCC accompanied by vascular invasion without extra-
hepatic metastasis [7].  However,  hepatectomy has been 
shown to have a survival benefit for patients with HCC 
with portal vein invasion [8].  Therefore,  surgical inter-
vention was performed in this patient.  Although hepa-
to-biliary-pancreatic surgery following prior abdominal 
surgery has been shown to be feasible,  several concerns 
regarding this course of treatment should be noted,  
including the higher risks of intraoperative organ injury 
and postoperative complications,  as well as the pro-
longed operative time and greater blood loss [9].
In esophagectomy followed by alimentary tract 
reconstruction using a gastric tube,  reconstruction can 
be achieved by either the retrosternal route or the pre-
vertebral route through the mediastinum [5].  Although 
there is an ongoing discussion as to which approach has 
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Fig. 1　 Contrast-enhanced computed tomography images.  (A),  The well-enhanced tumor in the arterial phase.  The gastric tube running 
through the retrosternal pathway and the right gastroepiploic artery (RGEA) are confirmed; (B),  The enhancement pattern of the portal 
phase revealing the tumor thrombus protruding into the left portal vein; (C),  The enhancement pattern of the venous phase showing rapid 
washout.  The middle hepatic vein is compressed by the tumor; (D),  The relationship between the tumor and the RGEA based on three-
dimensional imaging.
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Fig. 2　 Intraoperative findings.  (A),  The gastric tube and the right gastroepiploic artery (RGEA) were carefully dissected and encircled 
after the dissection of adhesions around the liver; (B),  Following left hemihepatectomy,  the gastric tube and the RGEA were preserved 
without incidental injury.
more advantages,  the prevertebral route might add less 
technical difficulty when performing hepatectomy fol-
lowing esophagectomy.  In our case,  the retrosternal 
route using the gastric tube interfered with the surgical 
field due to adhesion between the liver and the gastric 
tube.  Furthermore,  the right gastroepiploic artery,  
which runs along the gastric tube,  should be carefully 
dissected.  
With respect to the etiology of the HCC in this case,  
it is speculated that it developed due to previous alcohol 
abuse and/or HBV infection.  Chronic liver disease due 
to HBV and alcoholic liver disease are well known as 
major risk factors for HCC [10].  Although the patient 
consumed less alcohol after undergoing the esophagec-
tomy,  his previous alcohol abuse might have been 
related to the development of HCC.  In contrast,  nine 
years ago the serological markers for HBV demon-
strated an HBsAg seroconversion pattern,  which meant 
that this case developed HCC more than nine years 
after HBsAg seroclearance.  A recent study has reported 
that patients with HBsAg seroclearance had a signifi-
cantly lower incidence of HCC than those who were 
HBsAg positive; however,  the pooled incidence of 
HCC after HBsAg seroclearance was 1. 88% [11].  
Therefore,  a surveillance program for HCC should also 
be applied in patients who have shown HBsAg sero-
clearance.  
In conclusion,  we report the case of patient who 
underwent left hemihepatectomy for HCC following 
esophagectomy with retrosternal gastric tube recon-
struction for esophageal cancer.  Special attention 
should be paid to avoid incidental injuries during the 
hepatectomy,  such as injuries to the gastric tube and the 
right gastroepiploic artery.  
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